Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer. | J Exp Clin Cancer Res | 2025 | 40898244 | PubTator, text mining | PubMed |
| CD70 as a target in cancer immunotherapy: advances, challenges, and future directions. | Front Oncol | 2025 | 40896423 | PubTator, text mining | PubMed |
| A bispecific antibody-drug conjugate targeting CD7 and CD33 shows anti-tumor activity and improved tumor selectivity in an aggressive subtype of acute myeloid leukemia. | MAbs | 2025 | 40888053 | PubTator, text mining | PubMed |
| Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells. | Cell Rep Med | 2025 | 40885188 | PubTator, text mining | PubMed |
| Recent advances in universal chimeric antigen receptor T cell therapy. | J Hematol Oncol | 2025 | 40883768 | PubTator, text mining | PubMed |
| Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study. | Blood Cancer J | 2025 | 40883272 | PubTator, text mining | PubMed |
| Boosting Dendritic Cell Function in Cancer. | Cancer Med | 2025 | 40878038 | PubTator, text mining | PubMed |
| UPP1 is a dual biomarker of prognosis and immune microenvironment in IDH wild-type glioblastoma. | Sci Rep | 2025 | 40877486 | PubTator, text mining | PubMed |
| Quantitative Analysis of CD27/CD70 Protein Expression and Investigation of Related Mechanisms in the Tumor Microenvironment of NSCLC. | In Vivo | 2025 | 40877173 | PubTator, text mining | PubMed |
| [44Sc]Sc-CHX-A″-DTPA-RCCB6: A PET Tracer for Imaging CD70 Expression Across Latency Types of Burkitt Lymphoma. | J Nucl Med | 2025 | 40876953 | PubTator, text mining | PubMed |
| Proinflammatory Effect of Mesenchymal Stem Cells From Patients With Multiple Sclerosis: Potential Modulation Targets. | Neurol Neuroimmunol Neuroinflamm | 2025 | 40875958 | PubTator, text mining | PubMed |
| DNA methylation and transcription factor-driven immune subtypes in ovarian cancer. | Discov Oncol | 2025 | 40875153 | PubTator, text mining | PubMed |
| ECM-based molecular subtypes define prognostic, EMT status, and therapeutic diversity in IDH-mutant gliomas. | NPJ Precis Oncol | 2025 | 40866630 | PubTator, text mining | PubMed |
| Disarming a molecular brake: cAMP-responsive element modulator deletion supercharges CAR-NK cells. | Signal Transduct Target Ther | 2025 | 40866345 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T Cell Immunotherapy for Autoimmune Rheumatic Disorders: Where Are We Now? | Cells | 2025 | 40862721 | PubTator, text mining | PubMed |
| Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. | Signal Transduct Target Ther | 2025 | 40850976 | PubTator, text mining | PubMed |
| Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances. | J Exp Clin Cancer Res | 2025 | 40849493 | PubTator, text mining | PubMed |
| Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma. | Sci Rep | 2025 | 40830197 | PubTator, text mining | PubMed |
| Sex Differences in Inflammatory Plasma Proteins in Patients With Diabetic Retinopathy. | Transl Vis Sci Technol | 2025 | 40828525 | PubTator, text mining | PubMed |
| Epigenetic control in thyroid cancer: mechanisms and clinical perspective. | Cell Death Discov | 2025 | 40819127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=9